Development
Predictmedix AI Inc.
PMED
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 4.11% | -79.34% | -43.51% | -39.60% | 6.35% |
| Total Depreciation and Amortization | 4.23% | 150.00% | -74.49% | -40.17% | 1,320.00% |
| Total Amortization of Deferred Charges | -0.85% | -48.71% | -- | -52.23% | -- |
| Total Other Non-Cash Items | -100.00% | 3,716.67% | 555.56% | 433.39% | 262.50% |
| Change in Net Operating Assets | 505.08% | -200.04% | -273.54% | 24.10% | 65.53% |
| Cash from Operations | 54.92% | -24,023.08% | -435.99% | 65.62% | 41.30% |
| Capital Expenditure | -- | -- | -- | 49.93% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 89.63% | 100.00% |
| Cash from Investing | -- | -- | -- | 74.19% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 302.52% | -- | -0.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 81.73% | -- |
| Cash from Financing | -100.00% | 261.79% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.82% | -32.47% | 78.24% | 92.78% | 72.50% |